Clinical Trial Update: Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial updating results for combining immunotherapy with autologous stem cell transplantation in myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Pennsylvania | Conditions: Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2020-03-19